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 Introduction 
 Axons are indispensable for neuronal function but degenerate 
early in nervous system disorders ( Conforti et al., 2007a ). Distal 
stumps of injured axons undergo Wallerian degeneration ( Waller, 
1850 ), a regulated, nonapoptotic death program that models 
disease processes ( Coleman, 2005 ). 
 The slow Wallerian degeneration ( Wld S ) gene dominantly 
delays Wallerian degeneration 10-fold ( Mack et al., 2001 ; 
 Ferri et al., 2003 ;  Samsam et al., 2003 ;  Coleman, 2005 ).  Wld S 
was identifi ed by positional cloning ( Coleman et al., 1998 ; 
 Conforti et al., 2000 ) and replicates the protective phenotype 
in transgenic (Tg) mice ( Mack et al., 2001 ), rats, and  Drosoph-
ila melanogaster ( Adalbert et al., 2005 ;  Hoopfer et al., 2006 ; 
 MacDonald et al., 2006 ). It fuses the N-terminal 70 amino 
acids (N70) of multiubiquitination factor Ube4b in frame to 
the NAD + -synthesizing enzyme nicotinamide mononucleotide 
adenylyl transferase 1 (Nmnat1), separated by a short Wld18 
linker sequence. The parent proteins are unchanged. Wld S also 
delays axon degeneration in some diseases indicating similar 
mechanisms, particularly when axonal transport is blocked 
( Coleman, 2005 ). 
 Understanding how Wld S protects axons should help ex-
ploit its therapeutic potential and reveal the degenerative mech-
anism. In this study, we address the protein domains required 
in vivo and their roles. Overexpressing Nmnat1 in Tg mice is 
not suffi cient to protect axons ( Conforti et al., 2007b ), but in 
lentiviral-transduced primary culture, protection has been re-
ported ( Araki et al., 2004 ;  Wang et al., 2005 ). Thus, the N-terminal 
88 amino acids are required in vivo, and primary culture experi-
ments do not replicate the protective mechanism fully. How-
ever, the specifi c necessary sequences and their roles remain 
unknown. Moreover, reports that Nmnat1 blocks other types of 
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sequence from the Ube4b multiubiquitination factor with 
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zyme nicotinamide mononucleotide adenylyl transferase 1. 
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of Wld S -mediated neuroprotection remain highly contro-
versial. The Ube4b domain is necessary for the protective 
phenotype in mice, but precisely which sequence is essen-
tial and why are unclear. Binding to the AAA adenosine 
triphosphatase valosin-containing protein (VCP)/p97 is 
the only known biochemical property of the Ube4b do-
main. Using an in vivo approach, we show that removing 
the VCP-binding sequence abolishes axon protection. 
Replacing the Wld S VCP-binding domain with an alter-
native ataxin-3 – derived VCP-binding sequence restores its 
protective function. Enzyme-dead Wld S is unable to delay 
Wallerian degeneration in mice. Thus, neither domain is 
effective without the function of the other. Wld S requires both 
of its components to protect axons from degeneration.
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 Results and discussion 
 Variant Wld S Tg mice with an altered 
VCP-binding region 
 First, we tested the need for the VCP-binding sequence, ex-
pressing Wld S without amino acids 2 – 16 in   N16Wld S Tg mice 
(Fig. S1, available at http://www.jcb.org/cgi/content/full/jcb
.200807175/DC1). Two of the four lines expressed protein on 
brain Western blots ( Fig. 1 A ;  Samsam et al., 2003 ). Line 1 homo-
zygotes expressed similar levels to  Wld S heterozygotes. Line 2 
could not breed to homozygosity. Hemizygotes expressed slightly 
less, but still at a level where Wld S delays axon degeneration 
signifi cantly ( Mack et al., 2001 ). Nmnat activity matched or 
exceeded that in Wld S ( Fig. 1 E ), and lumbar spinal cord 
motor neurons, whose axons in the sciatic nerve we lesioned, 
express the protein ( Fig. 1 D ). The   N16Wld S variant showed 
a clear cytoplasmic signal, with no signifi cant difference in 
neurodegeneration in vivo without enzyme activity contrasts 
with primary culture data on axon degeneration, so a classical 
mammalian in vivo approach is needed to resolve this ( Araki 
et al., 2004 ;  Zhai et al., 2008 ). 
 N70 binds AAA ATPase valosin-containing protein (VCP) 
through a VCP-binding motif (VBM) in its N-terminal 16 amino 
acids (N16;  Boeddrich et al., 2006 ;  Morreale et al., 2009 ). In 
nuclei, in which Wld S is most easily visualized, VCP infl uences 
local Wld S targeting ( Wilbrey et al., 2008 ). Recent data indicate 
that Wld S can function in cytoplasm ( Beirowski et al., 2009 ), in 
which VCP is extremely abundant. Thus, VCP interaction also 
likely affects local targeting of cytoplasmic Wld S . 
 Early embryonic lethality precludes testing a role for VCP 
in null mice ( Muller et al., 2007 ). Thus, we generated Tg mice 
expressing variant Wld S with altered VCP-binding properties 
and lesioned their nerves. In view of the controversies over 
Nmnat activity, we also generated enzyme-dead Tg mice. 
 Figure 1.  Overexpression of   N16Wld S and ATX3Wld S in Tg mice. (A and B) Western blots of   N16Wld S and ATX3Wld S brains probed with Wld18. 
  N16Wld S lines 1 and 2 alone express a protein slightly smaller than Wld S . The 43-kD ATX3Wld S band matches that in  Wld S . (C) Brain Western blots of 
total homogenate and nuclear and cytoplasmic fractions of  Wld S ,   N16Wld S (line 1), and ATX3Wld S (line 6). The graph shows integrated band intensities 
of nuclear and cytoplasmic fractions normalized to H1 and   -actin, respectively. These normalized ﬁ gures were then expressed as a percentage of the total 
homogenate signal and normalized to the same respective markers (mean  ± SD;  n = 3). Statistical analysis was performed on the nuclear versus superna-
tant ratio using a Mann-Whitney test followed by a Bonferroni post-hoc test. (D) Immunoﬂ uorescence of lumbar spinal cord sections with Wld18 (red) and 
DAPI. Motor and interneuron nuclear signals in Tg   N16Wld S (i – iv) and ATX3Wld S (v – viii) show similar strength and distribution as  Wld S heterozygotes. 
Identical laser intensities and camera settings were used for each image. (E and F) Transgene products are enzymatically active. Nmnat activity is very 
signiﬁ cantly increased compared with wild-type (WT) brains in hemizygotes and homozygotes of all expressing Tg lines as well as  Wld S heterozygotes. 
Mean  ± SD; *, P  < 0.05; **, P  < 0.01; ***, P  < 0.001. Bars, 10  μ m. 
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In contrast,   N16Wld S was indistinguishable from wild type. 
Line 1 homozygotes and line 2 hemizygotes showed 2.3  ± 0.2% 
and 0.9  ± 0.2% surviving axons, respectively ( Fig. 2, a – d ; and 
Fig. S1). Axons lost continuity, as assessed by crossing to YFP-H 
Tg mice ( Beirowski et al., 2004 ), by 3 d ( Fig. 2, g and h ), 
which is a low stringency test ruling out even a weak protective 
phenotype. Axons in  Wld S heterozygotes maintain continuity 
even at 5 – 14 d ( Fig. 3 ). Finally, ultrastructural experiments 
confi rmed that axons of   N16Wld S mice retained little, if any, 
normal cytoskeleton and organelles after 3 d ( Fig. 2, i – l ). Thus, 
N16, which contains a VBM, is essential for Wld S to delay Wal-
lerian degeneration. 
 Replacing the VCP-binding site with the Atx-3 sequence 
restored strong axon protection similar to  Wld S . 5 d after nerve 
lesion, lines 1 and 6 showed highly signifi cant structural preser-
vation on semithin sections and retained axon continuity simi-
lar to  Wld S heterozygotes ( Fig. 3 A and Fig. S1). Axons in other 
lines were also protected (Fig. S2, available at http://www.jcb
.org/cgi/content/full/jcb.200807175/DC1). 
nuclear/cytoplasmic distribution relative to Wld S at  n = 3 ( Fig. 1, 
C and D , i – iv). 
 We then replaced N16 with a 16 – amino acid VCP-binding 
sequence from polyglutamine protein ataxin-3 (Atx-3; 277 –
 291 plus start Met, ATX3) sharing only fi ve residues (Fig. S1; 
 Boeddrich et al., 2006 ). At least 5 of 12 lines expressed protein, 
and most experiments used line 1 and 6 homozygotes. Again, we 
confi rmed protein expression and enzyme activity similar to or ex-
ceeding Wld S heterozygotes ( Fig. 1 ). Despite some variability, sub-
cellular localization of ATX3Wld S was not signifi cantly different 
from Wld S or   N16Wld S ( n = 3;  Fig. 1 C ), and the protein was in 
neuronal nuclei in the lumbar spinal cord ( Fig. 1 D , v – vii). 
 Effect of the VCP-binding region 
on phenotype 
 5 d after sciatic nerve lesion,  Wld S heterozygotes retained 69.7  ± 
1.8% of axons with normal cytoskeleton, unswollen mitochon-
dria, and a regular myelin sheath of normal thickness compared 
with only 1.2  ± 0.4% in wild-type mice ( Fig. 2 and Fig. S1). 
 Figure 2.  Rapid Wallerian degeneration in   N16Wld S  Tg mice. (a – d) Semithin sections of distal sciatic nerve 5 d after lesion. (a) Axons are well preserved 
in  Wld S heterozygotes, with intact myelin sheaths, uniform and regularly spaced cytoskeleton, and normal-shaped mitochondria. (b) Wild-type axons 
are degenerated, with collapsed myelin and disorganized or vacuolized cytoskeleton. (c and d)   N16Wld S line 1 homozygous and line 2 hemizygous 
nerves are indistinguishable from wild type. (e – h) Tibial nerves from mice crossed to YFP-H show rapid loss of axon continuity in   N16Wld S . (e)  Wld S 
heterozygotes 3 d after lesion show axon continuity. (f – h) In contrast, all lesioned wild-type and   N16Wld S line 1 and line 2 axons lose continuity within 
72 h. (i – l) Transmission electron microscopy of distal sciatic nerve 3 d after lesion. (i) Myelinated and unmyelinated axons are well preserved in  Wld S 
heterozygotes, which are indistinguishable from unlesioned nerves (l). (j) In wild type, myelin collapsed to form ovoids, the cytoskeleton is ﬂ occular or 
absent, and mitochondria are swollen or absent. (k) Nerves from   N16Wld S line 1 homozygotes are indistinguishable from wild types. Bars: (a – d) 
20  μ m; (e – h) 50  μ m; (i – l) 2  μ m. 
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remained in wild-type nerves. We then confi rmed that lesioned 
axons and their neuromuscular synapses remained functional for 
at least 3 d. Evoked action potentials in tibial nerve/fl exor digito-
rum brevis (FDB) preparations provoked robust contractile and 
electromyographic responses ( Fig. 4 A and Video 1, available at 
 We then applied more stringent tests to verify that ATX3-
Wld S mice have a full Wld S phenotype. 14 d after sciatic lesion, 
distal axons on semithin sections were structurally preserved, as 
in  Wld S (P  > 0.05). In whole-mount nerves, many YFP-H – labeled 
axons retained continuity ( Fig. 3 B and Fig. S1). Little but debris 
 Figure 3.  ATX3Wld S  Tg mice show a Wld S phenotype. (A, i – iv) Semithin sections of distal sciatic nerve 5 d after lesion. (i and ii) Most axons are well 
preserved in  Wld S heterozygotes (i), but wild-type nerves (ii) are completely degenerated. (iii and iv) Nerves from ATX3Wld S line 1 and line 6 show pres-
ervation similar to  Wld S heterozygotes. (v – viii) Confocal images of tibial nerve 5 d after sciatic lesion from mice crossed to YFP-H. (v)  Wld S heterozygotes 
maintain axon continuity. (vi) All wild-type axons are highly fragmented. (vii and viii) Many lesioned ATX3Wld S axons maintain continuity. (B, i, iii, and iv) 
Semithin sections of distal sciatic nerve show preserved axons (arrowheads) 14 d after lesion in  Wld S heterozygotes (i) and ATX3Wld S (iii and iv). 
(ii) Wild-type axons are completely degenerated and highly vacuolized. (v – viii) Confocal images of tibial nerves 14 d after sciatic nerve lesion in mice 
crossed to YFP-H. (v)  Wld S axons maintain continuity in contrast to the few remnants of the fragmented wild-type axons (vi). (vii and viii) Many axons in 
ATX3Wld S were also continuous at this stringent time point. Bars: (i – iv) 20  μ m; (v – viii) 50  μ m. 
495SEQUENCES REQUIRED FOR THE WLD S PHENOTYPE • Conforti et al. 
 Nmnat enzyme activity is required for the 
Wld S phenotype 
 Having shown that N16 is necessary for the Wld S phenotype 
in mice, we then tested the requirement for Nmnat activity in 
vivo and whether N16 and other N-terminal sequences, in-
cluding Wld18, are sufficient. We made Tg mice expressing 
enzyme-dead Wld S (W258A; Fig. S1) but retaining all 
N-terminal sequences. 
 Tg-expressing lines 2 and 4 showed no increase in brain 
Nmnat activity over wild type, whereas activity in  Wld S hetero-
zygotes increased two- to threefold ( Fig. 5, A and C ). As before, 
we confi rmed protein expression in motor neuron nuclei ( Fig. 5 B ) 
and we lesioned sciatic nerves. At the 3-d (low stringency) time 
point, homogeneous axoplasm and unswollen mitochondria 
could no longer be identifi ed in semithin sections ( Fig. 5 D , 
i and ii), and neither line retained axon continuity ( Fig. 5 D , 
v and vi). The third expressing line showed similar wild-type –
 like behavior (unpublished data). In contrast,  Wld S heterozygous 
http://www.jcb.org/cgi/content/full/jcb.200807175/DC1) that 
were absent in controls (Video 2). Immunostaining for preserved 
presynaptic structures of 3-d axotomized neuromuscular junction 
showed most endplates partially or fully occupied by motor nerve 
terminals connected to intramuscular motor axons ( Fig. 4 B ). 
 We then treated spinal cervical ganglia (SCG) explants 
from these mice with vincristine to confi rm these results using 
an assay in which axons are not cut ( Ravula et al., 2007 ). As 
reported, Wld S protected these axons ( Wang et al., 2001 ; 
 Conforti et al., 2007b ). Consistent with our in vivo data,   N16Wld S 
neurites degenerated at a wild-type rate, whereas ATX3Wld S 
neurites remained largely intact 5 d after vincristine applica-
tion (Fig. S2). 
 In summary, the Atx-3 – derived VCP-binding sequence re-
stores axon protective properties to   N16Wld S that are indistin-
guishable from  Wld S in terms of structure, long-term survival, and 
axonal and synaptic function. Collectively, these results strongly 
support a role of the VBM in Wld S -mediated axon protection. 
 Figure 4.  Functional motor innervation. (A) 
ATX3Wld S mice show robust preservation of 
neuromuscular function 3 d after nerve lesion. 
(i and ii) Isometric single twitch (i) and 20-Hz 
tetanic tension (ii) responses of isolated FDB to 
tibial nerve stimulation. (iii and iv) Averaged 
(16 sweeps) extracellular evoked EMG re-
sponses to stimulation of 3-d axotomized FDB 
from ATX3Wld S (iii) and  Wld S (iv). The x axis 
represents milliseconds, and the y axis repre-
sents millinewtons or microvolts. Bars: (i) 200 ms 
and 2 mN; (ii) 700 ms and 5 mN; (iii) 6 ms 
and 200  μ V; (iv) 12 ms and 200  μ V. (B) Con-
focal microscopy of axotomized FDB from an 
ATX3Wld S line 5 mouse in which physiologi-
cal recordings indicated robust preservation of 
neuromuscular function. Most motor endplates 
(TRITC –  -bungarotoxin staining; red) were in-
nervated by neuroﬁ lament-positive axon col-
laterals and motor nerve terminals (green), but 
  20% of endplates were unoccupied. (i) Low 
power z-series projection. (ii and iii) Higher 
magniﬁ cation images correspond to the boxed 
areas in panel i. 
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 Figure 5.  Rapid Wallerian degeneration in W258AWld S  Tg mice. (A) Brain Western blots from W258AWld S Tg,  Wld S , and wild-type mice probed with 
Wld18. W258AWld S lines 2 and 4 express a 43-kD band, which is absent in wild type. (B) Wld18 immunoﬂ uorescence (red) of lumbar spinal cord. Motor 
neuron nuclear signal strength and distribution in W258AWld S lines match  Wld S heterozygotes. Identical laser intensities and camera settings were used 
for each image. (C) Nmnat1 activity is unaltered in the W258AWld S brain. (D, i and ii) Semithin sections of W258AWld S distal sciatic nerve 72 h after 
lesion. Axons are degenerated, similar to wild-type or   N16Wld S axons ( Fig 2 ). (iii – vi) In mice crossed to YFP-H, tibial nerve axons lose continuity within 
72 h of sciatic lesion, except in Wld S (iii). (E) SCG explants untreated (i – iv) or treated (v – viii) with 100 nM FK866 for 72 h and then cut. Unlike wild-type 
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mice expressing a similar level of Wld S protein showed strong 
axon protection ( Fig. 5 D , iii; and Fig. S1). 
 We confi rmed rapid degeneration of injured W258AWld S 
neurites in SCG explant cultures and added 1 mM exogenous 
NAD + either 24 or 0 h before cutting. As we previously found in 
wild-type neurites ( Conforti et al., 2007b ), neither treatment al-
tered the rate of degeneration (Fig. S3 A, available at http://www
.jcb.org/cgi/content/full/jcb.200807175/DC1). Although we can-
not be sure how much NAD + entered the cells, these data are 
consistent with the notion that N16 and Nmnat activity must be 
physically linked in the same molecule to deliver Nmnat activity 
to a specifi c site. Thus, an intact VCP-binding region in N16 is 
not suffi cient to confer any Wld S phenotype in vivo without as-
sociated Nmnat activity, nor is N70 or even N70 + Wld18. 
 To test the causal link between NAD + production and axon 
protection, we then used FK866 to block the enzyme nicotinamide 
phosphoribosyltransferase. Nicotinamide phosphoribosyltrans-
ferase catalyzes the rate-limiting step for NAD + salvage from nic-
otinamide. FK866 strongly reduced NAD + or NADP + levels in 
Wld S SCG cultures ( Fig. 5 G ), and this was accompanied by a 
modest, partial reversion of the phenotype. Very few morphologi-
cally normal neurites remained in FK866-treated Wld S cultures 
72 h after cutting ( Fig. 5 E , vii and viii), whereas signifi cantly 
more intact neurites remained in untreated Wld S cultures ( Fig. 5, E 
[iii and iv] and  F ). After 6 d, there remained an obvious, statisti-
cally signifi cant difference (Fig. S3 B). These data suggest that 
NAD + synthesis is required for the Wld S phenotype, but the in-
complete reversion also suggests a need to consider other actions 
of Nmnat1 and/or other downstream metabolites. Alternatively, 
NAD + may be tightly regulated at specifi c loci in a way that the 
whole cell measurements do not refl ect. 
 Finally, we tested whether Nmnat1 chaperone activity con-
tributes to axon protection by Wld S . Chaperone activity in the 
W258A mutant protein was similar to that reported for enzyme-
dead Nmnat ( n = 3;  Zhai et al., 2008 ; and unpublished data), but 
as the mice show no axon protection, this is unlikely to be suffi -
cient for the Wld S phenotype. 
 By refi ning the N-terminal sequence needed for Wld S protein 
to preserve injured axons in mice and showing that Nmnat enzyme 
activity is also required to protect axons in vivo, we conclude that 
Wld S protects axons through a mechanism involving both of its 
parts. The absence of axon protection in   N16Wld S mice confi rms 
and extends our earlier data that Nmnat1 cannot substitute for Wld S 
protein at a similar expression level ( Conforti et al., 2007b ). The 
accompanying paper shows that the two proteins are also not 
equivalent in  Drosophila (see Avery et al. on p.  501 of this issue). 
However, Nmnat activity is required, and in Wld S , it works together 
with the N-terminal VCP-binding sequence to protect axons. The 
function of N16 now holds essential clues as to where this enzyme 
activity is needed and why, and it will be interesting to fi nd out 
whether other changes or additions to Nmnat1 can make it protec-
tive in vivo. 
 The only known biochemical property of N16 is binding 
VCP ( Laser et al., 2006 ). The VBM is highly conserved among 
vertebrates and some invertebrates ( Morreale et al., 2009 ), includ-
ing  Drosophila , which could help explain how murine Wld S can 
function there through a mechanism involving VCP ( Avery et al., 
2009 ). At the cellular level, recent data indicate that Wld S can func-
tion outside nuclei ( Beirowski et al., 2009 ), so we tested whether 
N16 binding to VCP (which is abundant in the cytoplasm as well 
as the nucleus) tethers some Wld S in the cytoplasm.   N16 variant 
is abundant in cytoplasm ( Fig. 1 C ), indicating that the functional 
importance of N16 is not solely to retain the protein in the cyto-
plasm. Instead, we propose a fi ner targeting role. As N16 binding 
to VCP infl uences local targeting of Wld S within nuclei ( Wilbrey 
et al., 2008 ), it likely has a similar local effect in cytoplasm. Thus, 
the critical function of N16 may be local targeting of Nmnat1 to a 
cytoplasmic site where it is needed for axon protection. 
 Such a model may explain why overexpressing wild-type 
Nmnat1 without N16 fails to produce any Wld S phenotype in Tg 
mice ( Conforti et al., 2007b ), whereas overexpression in lentiviral-
transduced cultures or in  Drosophila does reproduce the pheno-
type to some extent ( Araki et al., 2004 ;  Hoopfer et al., 2006 ; 
 MacDonald et al., 2006 ). In higher expressing systems with 
shorter axons, Nmnat1 may reach levels at which focal targeting 
becomes unnecessary. However, high Nmnat1 expression levels 
could also trigger unrelated mechanisms. 
 The local targeting model raises two important questions: 
what is the critical site, and what does Nmnat1 do there? A local 
bioenergetics mechanism for NAD + within mitochondria has been 
proposed ( Wang et al., 2005 ). However, the ability of Wld S to 
maintain axonal NAD + and ATP levels could be an effect of axon 
survival rather than a cause, and how VCP binding and N16 fi t 
such a model is not clear. Further investigations of VCP in mito-
chondria could shed light on this issue ( Braun et al., 2006 ). An al-
ternative location that does connect VCP and NAD + is the ER. 
VCP is particularly abundant here ( Ye et al., 2005 ), and NAD + is 
a key upstream regulator of calcium signaling in this organelle 
through enzymes such as CD38 ( Macgregor et al., 2007 ). 
 NAD + is also a substrate for the sirtuin family of histone 
deacetylases ( Yang and Sauve, 2006 ) and for the ADP ribo-
sylase PARP-1 ( Kim et al., 2005 ), and Nmnat protects against reac-
tive oxygen species ( Press and Milbrandt, 2008 ). A Sirt1-mediated 
mechanism ( Araki et al., 2004 ) is not supported by subsequent 
data ( Wang et al., 2005 ;  Conforti et al., 2007b ;  Avery et al., 
2009 ), but these other possibilities remain plausible. However, a 
chaperone-mediated mechanism for axon protection ( Zhai et al., 
2008 ) is not supported by our data. 
 Other functions of VCP include roles in the cell cycle, homo-
typic membrane fusion, nuclear envelope reconstruction, post-
mitotic Golgi reassembly, DNA damage response, suppression of 
apoptosis, ER-associated protein degradation, and ubiquitin-
dependent protein degradation ( Watts et al., 2004 ). Thus, if the crit-
ical function of N16 is binding to VCP, one or more of these sites 
axons (i, ii, v, and vi), untreated Wld S axons are intact 72 h after being cut (iv) but when treated with FK866 are more degenerated (viii). (F) Quantiﬁ cation 
of continuous neurites (or neurite bundles). ***, P  < 0.0001 (one-way analysis of variance followed by Bonferroni post-hoc test);  n = 8 (wild type [WT]) 
and 9 ( Wld S ). (G) NAD +  or NADP +  levels in wild-type and Wld S explants  ± FK866 at 1 – 100 nM. Mean of three different experiments. (C, F, and G) Mean  ± SD. 
Bars: (B, D, i and ii, and E) 10  μ m; (D, iii – vi) 100  μ m. 
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 Materials and methods 
 Generation of Tg mice 
 The   N16Wld S Tg construct was generated as previously reported 
( Mack et al., 2001 ;  Conforti et al., 2007b ) using the forward PCR 
primer 5  -TAGCCC AAGCTT TAGAGGAAAGCG ATG CTTGCTGGTGGA-
CAGACCTC-3  (5  HindIII tag and start codon underlined). For the 
ATX3Wld S construct, the primer 5  -AGCCC AAGCTT TAGAGGAAAGCG-
 ATG ACTTCAGAAGAGCTTCGGAAGAGACGAGAAGCCTACTTGAAAAA CTT-
GCTGGTGGACAGACCT -3  (5  HindIII tag and start codon underlined, 
Atx-3 sequences in bold, and Wld S sequences in bold and italic) and its re-
verse complement were annealed and mixed with linearized   N16Wld S . 
The mix was used as a template for PCR with the reverse primer that has 
been previously described ( Mack et al., 2001 ;  Conforti et al., 2007b ) and 
the forward primer 5  -AGCCC AAGCTT TAGAGGAAAGCG ATG ACTTC-3  
(5  HindIII tag and start codon underlined). For the W258AWld S construct, 
tryptophan 258 of Wld S was mutated to an alanine using the QuikChange 
Site-Directed Mutagenesis kit (Agilent Technologies) with the primer 
5  -GCGTGCCCAACTTG GCG AAGATGGAGGAC-3  and its reverse com-
plementary primer (W → A mutation underlined). 
 Pronuclear injection of the EcoRI – NdeI fragments (Fig. S1) into an 
F1 C57BL-CBA strain was performed by the in-house Gene Targeting Facility. 
Animal work was performed in accordance with the 1986 Animals (Scien-
tiﬁ c Procedures) Act under project licence PPL 80/1778. 
 Genotyping 
 Tg mice were identiﬁ ed by Southern blotting as described previ-
ously ( Conforti et al., 2007b ). YFP-H mice ( Feng et al., 2000 ) were 
obtained from The Jackson Laboratory and genotyped by Southern 
blotting (YFP probe generated by PCR from YFP-H mouse genomic 
DNA using the primers 5  -CGAACTCCAGCAGGACCATGTGAT-3  and 
5  -CTT CTTCAAGGACGACGGCAACTACAAG-3  ). 
 Western blotting and Nmnat enzyme activity assay 
 Western blotting and Nmnat enzyme activity assays of sagittally divided 
half brains were performed as described previously ( Conforti et al., 
2007b ). Subcellular fractionation of the nuclear and cytoplasmic com-
partments was performed as described previously ( Beirowski et al., 
2009 ). For these experiments,  Wld S heterozygotes,   N16Wld S line 1, 
and ATX3Wld S line 6 mice were used. In addition to Wld18 (1:2,000), 
mouse monoclonal anti – histone H1 (1:500; Millipore) and mouse mono-
clonal anti –  -actin (1:5,000; Abcam) were used as loading controls for 
the nuclear and the cytoplasmic fraction, respectively. All subcellular pel-
lets were resuspended in the same volume as the starting total homoge-
nate. Identical volumes of each fraction were loaded on the gels. For 
quantiﬁ cation, Western blot band intensities were determined with ImageJ 
software (National Institutes of Health) and analyzed as described in the 
ﬁ gure legends. 
 Statistical analysis was performed using one-way analysis of vari-
ance followed by Dunnett ’ s  t post-hoc test or, when this was not applicable, 
by Kruskall-Wallis analysis followed by Mann-Whitney tests. 
 Immunocytochemistry 
 20- μ m cryostat lumbar spinal cord sections of 4% paraformaldehyde 
perfusion-ﬁ xed mice were immunostained for Wld18 and imaged as 
described previously ( Conforti et al., 2007b ). Isolated FDB muscles 
were whole-mount immunostained for neuroﬁ lament and/or SV2, and 
acetylcholine receptors at motor endplates were counterstained with 
TRITC –  -bungarotoxin and imaged as described previously ( Gillingwater 
et al., 2002 ). 
 Acquisition and processing of images 
 Bright ﬁ eld images were acquired on a microscope (IX8I; Olympus) cou-
pled to a digital camera (U-TV 0.5XC; Olympus) using AnalySIS software 
(Soft Imaging System, GmbH). The objectives used were UPlanFI 4 × NA 
0.13, UPLanFI 10 × NA 0.3, LCPlanFI 20 × NA 0.40 (all air objectives), 
and UPLanSApo oil immersion 100 × NA 1.40. Confocal ﬂ uorescent im-
ages were acquired using a confocal microscope system (LSM 510 Meta; 
Carl Zeiss, Inc.) built around an Axiovert 200 (Carl Zeiss, Inc.), and z se-
ries were merged using algorithms from LSM Software Release 3.2 (Carl 
Zeiss, Inc.). For colocalization analysis, the multitrack conﬁ guration mode 
was applied to avoid signal cross talk between individual ﬂ uorophores. 
The objectives used were Plan-Neoﬂ uar 20 × NA 0.5 and oil immersion 
Plan-Apochromat 63 × NA 1.4. Tissue preparations were mounted in 
Vectashield medium (Vector Laboratories). The ﬂ uorophores used were YFP 
could be important. VCP also has many associations with neuro-
degenerative disease as a component of intranuclear and cyto-
plasmic aggregates ( Kobayashi et al., 2007 ), as the mutated gene 
in the rare neurological disorder inclusion body myopathy asso-
ciated with Paget disease of bone and frontotemporal dementia 
( Watts et al., 2004 ), and through binding to Atx-3 and other 
polyglutamine proteins ( Hirabayashi et al., 2001 ;  Boeddrich 
et al., 2006 ). 
 As there are no null or conditional null VCP mice, VCP-
independent mechanisms cannot be tested further using in vivo 
mouse experiments. We cannot rule out a role for other amino 
acids in common between the Atx-3 – derived VCP-binding se-
quence and N16 or an infl uence on Wld S turnover. However, in 
 Drosophila , where targeted RNAi in specifi c neurons overcomes 
lethality, VCP knockdown signifi cantly weakens the Wld S pheno-
type ( Avery et al., 2009 ). Collectively, these data strongly suggest 
that VCP binding is the critical property of this sequence that is 
required for the phenotype. 
 Like other chimeric proteins, Wld S has a biological activity 
that requires both of its parts. In other cases, this can be the result 
of a conformational change that confers a new property such as 
affi nity for a different receptor in the case of a ligand ( Campbell 
et al., 1997 ). The combination of two different proteins to form a 
chimera often arises from chromosome translocations or gene 
duplications and has evolutionary relevance. Wld S arose in the 
laboratory mouse, so it is not the result of generations of adaptive 
mutations. Nevertheless, this is another intriguing example of 
how protein domains can be combined to produce a completely 
new function. 
 The impressive correlation between the phenotypes of 
 Wld S mice, rats, and  Drosophila , each carrying the mouse 
cDNA, indicates that the degenerative pathway that it blocks 
is well conserved in evolution. Even in  Drosophila , Nmnat1 
cannot fully substitute for Wld S in conferring axon protec-
tion, although a weak effect can be obtained from Nmnat1 
over expression alone, maybe refl ecting higher expression 
levels reached in the fl y with the use of a different promoter 
( MacDonald et al., 2006 ;  Avery et al., 2009 ). VCP-binding se-
quences are required for the full Wld S phenotype in  Drosophila 
as well as in mice, and down-regulation of ter94, the  Drosophila 
homologue of VCP, signifi cantly weakens the phenotype ( Avery 
et al., 2009 ). These similarities validate  Drosophila as a model 
to study axon degeneration and protection by Wld S and demon-
strate how  Drosophila experiments can provide information not 
easily obtainable in the mouse. 
 In summary, we show that N16, which contains a VBM, is 
necessary for Wld S to delay Wallerian degeneration, and this se-
quence acts together with Nmnat1 activity. In this study, we pro-
pose a new model for Wld S action that explains the requirement 
of both N-terminal Ube4b-derived sequence and Nmnat1 en-
zyme activity. Having strongly implicated VCP binding in the 
protective mechanism and having shown that VCP binding helps 
direct the subcellular distribution of Wld S , we suggest that the 
role of the N-terminal region is to deliver Nmnat activity to an 
important, specifi c subcellular site. Further studies are necessary 
to identify this specifi c site and to understand what Nmnat1 does 
there to produce the Wld S phenotype. 
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and Alexa Fluor 568. Nuclei were stained with DAPI. All images were ac-
quired at room temperature. 
 Nerve lesion 
 Mice were anaesthetized with a mixture of 100 mg/kg ketamine (Fort 
Dodge Animal Health) and 5 mg/kg xylazine (Pﬁ zer). Right sciatic nerves 
were transected at the upper thigh, and mice were killed by cervical disloca-
tion 72 h to 14 d later. The swollen ﬁ rst 2 mm of distal nerve was discarded, 
and the remaining sciatic nerve stump was used for light and electron micros-
copy (see following section). For YFP-H mice, the tibial nerve was removed 
for confocal microscopy. 
 Light and electron microscopy 
 Nerves were ﬁ xed for at least 24 h in 0.1 M of phosphate buffer containing 
4% paraformaldehyde and 2.5% glutardialdehyde, embedded in Durcupan 
resin (Fluka), and processed for light and electron microscopy as previously 
described ( Beirowski et al., 2004 ). 
 Electrophysiology 
 Mice were killed by cervical dislocation. Isometric tension recordings 
and electromyography (EMG) were performed as described previously 
( Barry and Ribchester, 1995 ;  Costanzo et al., 1999 ). Tibial nerve/FDB 
preparations were dissected, pinned to a Sylgard-lined dish, bathed in 
oxygenated mammalian physiological saline (137 mM Na + , 4 mM K + , 
2 mM Ca 2+ , 1 mM Mg 2+ , 147 mM Cl, 5 mM glucose, and 5 mM 
Hepes, pH 7.2 – 7.4, equilibrated with 100% oxygen), connected either 
to a sensitive force transducer via their tendons or to a pair of stainless 
steel wires insulated within 500  μ m of their tips, and inserted into the 
belly of the isolated muscle. The tibial nerve was stimulated using a suc-
tion electrode and tension, or EMG recordings were made on a laptop 
computer (Macintosh G4; Apple) using Chart version 4.1.1 (ADInstru-
ments Ltd.) and Scope version 3.6.8 (ADInstruments Ltd.) software via a 
Powerlab 4/20T interface (ADInstruments Ltd.). Nerves were stimulated 
using 50 – 200- μ s pulses, with 0.1 – 1-mA intensity at 1 – 20 Hz either 
from the Powerlab unit or using an isolated pulse stimulator (model 
210; A-M Systems) supplying variable 1 – 10-V pulses for 200  μ s in du-
ration and at frequencies of 1 – 40 Hz. In some experiments, muscle 
contractions were also recorded as short videos through a dissecting 
microscope (Wild M5A; Spectra Services) using a digital camera (Cool-
pix 4500; Nikon). 
 Analysis of YFP-labeled nerves 
 Sciatic and tibial nerves were quickly removed from humanely killed mice, 
processed, and imaged as described previously ( Conforti et al., 2007b ). 
 SCG explant cultures and NAD +  or NADP +  assay 
 SCG explants were dissected, cultured, and lesioned as previously de-
scribed ( Buckmaster et al., 1995 ). Neurites were allowed to extend for 7 d 
in all cultures before any treatment. In vincristine experiments, this was 
used at a 0.02- μ M ﬁ nal concentration, and the day of treatment was con-
sidered time 0. In experiments with FK866, the appropriate concentration 
was applied, and the cultures were kept for 72 h in the presence of the 
drug. At this time, some of the explants were collected in 100 ml H 2 O for 
NAD +  or NADP +  determination as described in  Billington et al. (2008) . 
Other explants were cut, and the degeneration of the distal axons followed 
for another 72 h. 
 Online supplemental material 
 Fig. S1 shows the constructs used to generate Tg mice and the quantiﬁ ca-
tion of axon survival. Fig. S2 shows the survival of ATX3Wld S and 
  N16Wld S axons in vivo and in vitro. Fig. S3 shows the effects of increas-
ing and decreasing NAD + . Videos 1 and 2 show the contraction of stimu-
lated ATX3Wld S and wild-type FDB muscle, respectively, 3 d after sciatic 
nerve lesion. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200807175/DC1. 
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